This invention provides a vaccine for stimulating or enhancing in a subject
to which the vaccine is administered, production of an antibody which recognizes
a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof
conjugated to an immunogenic protein effective to stimulate or enhance antibody
production in the subject, an effective amount of adjuvant and a pharmaceutically
acceptable vehicle.
